Jane Street
HTGM

Jane Street’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History

Jane Street’s Portfolio HTGM Stock Details HTGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-210
Closed -$27K – 8213
2020
Q2 		$27K Buy
+210
New +$18.6K ﹤0.01% 6943
2019
Q1 		– Sell
-59
Closed -$27K – 5854
2018
Q4 		$27K Buy
+59
New +$36.6K ﹤0.01% 4771

Other funds holding HTGM

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CPA
Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $33.2B AUM 25.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jane Street's HTGM Position: Q3 2020 in Review

Jane Street sold out of HTG Molecular Diagnostics, Inc. Common Stock (HTGM) in Q3 2020, closing a stake of 210 shares — an estimated $27K sold.

Jane Street first reported a position in HTGM in Q4 2018 and held it in 2 quarters. The position peaked at $27K in Q2 2020. 28 funds tracked by Wall St. Rank hold HTGM as of Q3 2020.

  • Jane Street reported no remaining HTG Molecular Diagnostics, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Jane Street sold 210 HTG Molecular Diagnostics, Inc. Common Stock shares in Q3 2020, an estimated $27K.
  • Jane Street first reported a position in HTG Molecular Diagnostics, Inc. Common Stock in Q4 2018 and held it in 2 quarters.
  • Jane Street's HTG Molecular Diagnostics, Inc. Common Stock position peaked at $27K in Q2 2020.
  • 28 funds tracked by Wall St. Rank held HTG Molecular Diagnostics, Inc. Common Stock as of Q3 2020.

Based on Jane Street's 13F filing for Q3 2020, filed 17 Nov 2020.